Medical startup Kailo is developing the first-ever medication designed to directly treat post-traumatic stress disorder (PTSD). It follows research at the University of Haifa in which scientists are developing a peptide to neutralize the pathological “amplification” of fear memories..
https://www.calcalistech.com/ctechnews/article/skjngqp9bl